Richard Law
Stock Analyst at Goldman Sachs
Total Price Targets
14
Stocks Covered
10
Sectors
Healthcare
Most Recent
Feb 11, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Richard Law
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. Common Stock | $14.00 | $21.90 | -36.1% | 1 | Feb 11, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $67.00 | $38.93 | +72.1% | 2 | Jan 12, 2026 |
| RCUS | Arcus Biosciences, Inc. | $28.00 | $25.66 | +9.1% | 1 | Jan 12, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $29.00 | $23.37 | +24.1% | 1 | Oct 30, 2025 |
| RCKT | Rocket Pharmaceuticals, Inc. | $2.00 | $3.56 | -43.9% | 2 | May 28, 2025 |
| OLMA | Olema Pharmaceuticals, Inc. | $27.00 | $14.47 | +86.5% | 2 | Oct 24, 2024 |
| VRDN | Viridian Therapeutics, Inc. | $25.00 | $13.41 | +86.4% | 2 | Aug 14, 2024 |
| MLYS | Mineralys Therapeutics, Inc. | $30.00 | $29.07 | +3.2% | 1 | Apr 2, 2024 |
| MLTX | MoonLake Immunotherapeutics | $62.00 | $16.71 | +271.0% | 1 | Apr 2, 2024 |
| KYMR | Kymera Therapeutics, Inc. | $32.00 | $81.54 | -60.8% | 1 | Dec 6, 2022 |
Recent Activity
- Feb 11, 2026— Set$14.00price target onBCAX(Bicara Therapeutics Inc. Common Stock)
- Jan 12, 2026— Set$67.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- Jan 12, 2026— Set$28.00price target onRCUS(Arcus Biosciences, Inc.)
- Oct 30, 2025— Set$29.00price target onARQT(Arcutis Biotherapeutics, Inc.)
- Jul 10, 2025— Set$36.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- May 28, 2025— Set$2.00price target onRCKT(Rocket Pharmaceuticals, Inc.)
- Oct 24, 2024— Set$27.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- Aug 14, 2024— Set$25.00price target onVRDN(Viridian Therapeutics, Inc.)
- Jun 6, 2024— Set$11.50price target onVRDN(Viridian Therapeutics, Inc.)
- Apr 2, 2024— Set$24.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- Apr 2, 2024— Set$39.00price target onRCKT(Rocket Pharmaceuticals, Inc.)
- Apr 2, 2024— Set$30.00price target onMLYS(Mineralys Therapeutics, Inc.)
- Apr 2, 2024— Set$62.00price target onMLTX(MoonLake Immunotherapeutics)
- Dec 6, 2022— Set$32.00price target onKYMR(Kymera Therapeutics, Inc.)
Frequently Asked Questions
Who is Richard Law?
Richard Law is a stock analyst at Goldman Sachs covering 10 stocks primarily in Healthcare. They have issued 14 price targets since Dec 6, 2022.
What stocks does Richard Law cover?
Richard Law currently covers 10 stocks, including CRNX, RCKT, OLMA, VRDN, BCAX.
What is Richard Law's latest price target?
Richard Law's most recent price target was $14.00 on BCAX (Bicara Therapeutics Inc. Common Stock), set on Feb 11, 2026.
What is Richard Law's highest price target?
Richard Law's highest issued price target is $67.00 on CRNX, set on Jan 12, 2026.
More Analysts at Goldman Sachs
Coverage based on publicly published price targets. Not investment advice.